Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.00 |
|---|---|
| High | 3.00 |
| Low | 3.00 |
| Bid | -- |
| Offer | -- |
| Previous close | 3.00 |
| Average volume | -- |
|---|---|
| Shares outstanding | 8.14m |
| Free float | 5.31m |
| P/E (TTM) | -- |
| Market cap | 6.37m USD |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Feb 28 2023 09:07 GMT.
More ▼
Announcements
- Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
- DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference
- Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering
- As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives
- Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
- DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR’s APOE Genotyping Test
- Aptorum Group Limited Regains Compliance with NASDAQ’s Minimum Bid Price Requirement
- Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement
- Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
More ▼
